Biotron Limited
BITRF · OTC
6/30/2025 | 6/30/2024 | 6/30/2023 | 6/30/2022 | |
|---|---|---|---|---|
| Revenue | $1,814 | $1,645 | $1,431 | $1,559 |
| % Growth | 10.2% | 14.9% | -8.2% | – |
| Cost of Goods Sold | $0 | $40 | $43 | $45 |
| Gross Profit | $1,814 | $1,605 | $1,388 | $1,513 |
| % Margin | 100% | 97.5% | 97% | 97.1% |
| R&D Expenses | $535 | $3,625 | $3,232 | $2,821 |
| G&A Expenses | $769 | $528 | $1,626 | $1,116 |
| SG&A Expenses | $1,513 | $1,396 | $1,626 | $1,116 |
| Sales & Mktg Exp. | $744 | $867 | $0 | $0 |
| Other Operating Expenses | $103 | $130 | $181 | $400 |
| Operating Expenses | $2,152 | $5,151 | $5,039 | $4,338 |
| Operating Income | -$339 | -$3,506 | -$3,608 | -$2,776 |
| % Margin | -18.7% | -213.1% | -252.1% | -178.1% |
| Other Income/Exp. Net | $20 | $70 | $115 | -$2 |
| Pre-Tax Income | -$319 | -$3,437 | -$3,493 | -$2,781 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$319 | -$3,437 | -$3,493 | -$2,781 |
| % Margin | -17.6% | -208.9% | -244% | -178.4% |
| EPS | -0 | -0.004 | -0.004 | -0.004 |
| % Growth | 92.1% | 11.6% | -13.2% | – |
| EPS Diluted | -0 | -0.004 | -0.004 | -0.004 |
| Weighted Avg Shares Out | 1,001,799 | 902,212 | 820,842 | 724,786 |
| Weighted Avg Shares Out Dil | 999,228 | 902,170 | 820,842 | 724,786 |
| Supplemental Information | – | – | – | – |
| Interest Income | $20 | $71 | $120 | $3 |
| Interest Expense | $0 | $1 | $4 | $5 |
| Depreciation & Amortization | $5 | $2 | $6 | $45 |
| EBITDA | -$334 | -$3,504 | -$3,602 | -$2,731 |
| % Margin | -18.4% | -213% | -251.6% | -175.2% |